Mesoblast Limited Share Price
NASDAQ: MESOMesoblast Limited Stock Performance
Mesoblast Limited Share Price Today
As of 30 October 2026, Mesoblast Limited's share price is $15.68. The stock opened at $15.66, compared to its previous close of $13.38. During today's trading session, Mesoblast Limited's share price traded between $15.31 and $15.82, with an average price of $15.57. Over the past 52 weeks, the stock has recorded a high of $21.48 and a low of $11.89. In terms of performance, Mesoblast Limited's share price has declined by 0.03% over the last six months and is down 5.88% on a year-on-year basis.
Mesoblast Limited Share Price Chart
About Mesoblast Limited
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.
Mesoblast Limited Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $14.35 | $15.63 | +6.44% |
Sep 2026 | $16.48 | $14.68 | -19.34% |
Aug 2026 | $14.05 | $18.20 | +28.26% |
Jul 2026 | $14.01 | $14.19 | +4.68% |
Jun 2026 | $15.02 | $13.55 | -11.98% |
May 2026 | $15.73 | $15.40 | -1.79% |
Apr 2026 | $15.78 | $15.68 | +1.85% |
Mar 2026 | $14.96 | $15.39 | -2.50% |
Feb 2026 | $17.22 | $15.79 | -8.49% |
Jan 2026 | $18.45 | $17.25 | -4.25% |
Dec 2025 | $17.53 | $18.02 | +4.46% |
Nov 2025 | $16.30 | $17.25 | +3.57% |